Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1984 Oct;26(4):498–500. doi: 10.1128/aac.26.4.498

Antibacterial activities of nitrothiazole against Campylobacter jejuni and Campylobacter coli.

H Hof, M Rieffert, V Sticht-Groh, O Zak, E H Schweizer
PMCID: PMC179952  PMID: 6517542

Abstract

Niridazole (Ambilhar) and three other newly synthesized nitrothiazole derivatives were highly active against 19 microaerophilic campylobacters (minimum concentration required to inhibit 50% of strains [MIC50], 0.0075 to 0.015 mg/liter). There were, however, considerable differences in the susceptibility among strains tested, and one nitrothiazole derivative was rather inactive (MIC50, 2 mg/liter). Nitroimidazole derivatives, such as metronidazole and tinidazole, were less active (MIC50, 2 and 4 mg/liter, respectively). The nitrofuran derivatives, such as nitrofurazone and nitrofurantoin, were also less active (MIC50, 1 mg/liter). Niridazole and another potent nitrothiazole derivative killed the campylobacters rapidly at low concentrations. In contrast, much higher concentrations of metronidazole were required to achieve bactericidal values.

Full text

PDF
498

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Freydière A. M., Gille Y., Tigaud S., Vincent P. In vitro susceptibilities of 40 Campylobacter fetus subsp. jejuni strains to niridazole and metronidazole. Antimicrob Agents Chemother. 1984 Jan;25(1):145–146. doi: 10.1128/aac.25.1.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. George H. A., Hoffman P. S., Smibert R. M., Krieg N. R. Improved media for growth and aerotolerance of Campylobacter fetus. J Clin Microbiol. 1978 Jul;8(1):36–41. doi: 10.1128/jcm.8.1.36-41.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Hof H., Müller K. M. Antibakterielle Wirkung von Niridazol. II. Wirkung auf aerobe und anaerobe Bakterien. Zentralbl Bakteriol Mikrobiol Hyg A. 1982 Nov;253(2):265–271. [PubMed] [Google Scholar]
  4. Hof H., Sticht-Groh V. Antibacterial effects of niridazole: its effect on microaerophilic campylobacter. Infection. 1984 Jan-Feb;12(1):36–39. doi: 10.1007/BF01641023. [DOI] [PubMed] [Google Scholar]
  5. Hof H., Sticht-Groh V., Müller K. M. Comparative in vitro activities of niridazole and metronidazole against anaerobic and microaerophilic bacteria. Antimicrob Agents Chemother. 1982 Aug;22(2):332–333. doi: 10.1128/aac.22.2.332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Jordan P. Trial of ambilhar, a nitrothiazole derivative, in S. mansoni infections in Tanzania. Br Med J. 1966 Jan 29;1(5482):276–278. doi: 10.1136/bmj.1.5482.276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Skirrow M. B. Campylobacter enteritis: a "new" disease. Br Med J. 1977 Jul 2;2(6078):9–11. doi: 10.1136/bmj.2.6078.9. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES